Axial Biotech
Joe Ross, Vice President of Strategic Initiatives

Axial Biotech is poised to revolutionize spine care through the development of molecular diagnostic and motion preserving technologies. Delivering the promise of personalized medicine to spine surgeons and their patients, Axial will transform spine treatment paradigms by using its DNA-based predictive tests to bring the right care to the right patient at the right time.